Overview
Living
and breathing with asthma has become not only a complex public health
issue but also one of epidemic proportions. It is complex because of
the many environmental factors that have been discovered to trigger
asthma; and it is epidemic because since 1980 the numbers of cases have
doubled to an estimated 15 million.
The more we learn, the more we find
we don't know. In this discovery process, it has been determined
that three strategies will reduce the severity of asthma: eliminating
environmental triggers, ensuring appropriate medical management and
implementing surveillance that will help us gain a greater understanding
of the problem. Public Health Grand Rounds will explore these strategies
and profile a New York City community's initiative to beat asthma
in the environment and gain control over this 21st century epidemic.
Goal
The goal of this Public Health Grand
Rounds is to increase awareness of the asthma epidemic and promote
a national dialogue among public health leaders and
professionals on environmental risk factors and the efforts aimed
at reducing them.
Objectives
- List three contributing factors to
the increase in the severity of asthma.
- Discuss key factors that determine
what is known and not known about the causes of asthma.
- Describe the importance of asthma surveillance
in targeting interventions for asthma.
- Identify two community interventions
likely to reduce the severity of asthma.
Audience
This Public Health Grand
Rounds presentation is designed for public health leaders, managers,
and professionals from local and state health departments, hospitals,
clinics, academic institutions, managed care organizations, and others
who seek to increase awareness of the environmental risk factors
of asthma and the surveillance and interventions that are being implemented
to combat this epidemic.
No presenter in this program has a financial interest or other relationship
with manufacturers of commercial products, providers of commercial services
or commercial supporters.
No presenter in this program will discuss the unlabeled use of commercial
products or products for investigational use.
|